Vascular Solutions (VASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Sales | 25,304 | 24,552 | 24,737 | 23,793 | 22,097 |
| Cost of Goods | 8,309 | 8,183 | 8,231 | 7,838 | 7,582 |
| Gross Profit | 16,995 | 16,369 | 16,506 | 15,955 | 14,515 |
| Operating Expenses | 12,616 | 12,402 | 12,797 | 13,666 | 11,641 |
| Operating Income | 4,688 | 4,150 | 3,940 | 3,127 | 3,456 |
| Interest Expense | 0 | 3 | 3 | 3 | 3 |
| Other Income | 7 | 9 | -25 | 5 | -3 |
| Pre-tax Income | 4,695 | 4,156 | 3,912 | 3,129 | 3,450 |
| Income Tax | 1,644 | 1,591 | 1,528 | 1,220 | 1,291 |
| Net Income Continuous | 3,051 | 2,565 | 2,384 | 1,909 | 2,159 |
| Net Income | $3,051 | $2,565 | $2,384 | $1,909 | $2,159 |
| EPS Basic Total Ops | 0.19 | 0.16 | 0.15 | 0.12 | 0.14 |
| EPS Basic Continuous Ops | 0.19 | 0.16 | 0.15 | 0.12 | 0.13 |
| EPS Diluted Total Ops | 0.17 | 0.16 | 0.15 | 0.12 | 0.12 |
| EPS Diluted Continuous Ops | 0.18 | 0.16 | 0.15 | 0.12 | 0.13 |
| EBITDA(a) | $5,629 | $5,048 | $4,802 | $3,977 | $4,218 |